M06.369 Rheumatoid nodule, unspecified knee

Name of the Condition

• Rheumatoid nodule, unspecified knee

Summary

Rheumatoid nodule, unspecified knee is a localized extra-articular manifestation of rheumatoid arthritis (RA) involving firm, subcutaneous nodules in the knee region. These nodules are composed of inflammatory tissue and are associated with chronic, seropositive RA. They may occur in other conditions but are most strongly linked to RA. Diagnosis relies on clinical recognition and correlation with underlying joint disease.

Causes

Rheumatoid nodules form due to chronic inflammation and immune complex deposition in subcutaneous tissues. The exact pathogenesis involves dysregulated immune responses, including the activation of fibroblast-like synoviocytes and the production of pro-inflammatory cytokines. Genetic factors, such as HLA-DRB1 alleles, and environmental triggers (e.g., smoking) may contribute to their development in individuals with RA.

Risk Factors

• Severe, long-standing rheumatoid arthritis (especially seropositive disease).
• High rheumatoid factor or anti-CCP antibody titers.
• Presence of other extra-articular RA manifestations (e.g., vasculitis).
• Chronic inflammation and immune dysregulation.
• Trauma or pressure to affected areas.

Symptoms

• Firm, movable subcutaneous nodules in the knee area.
• Nodules may be painless or tender.
• May be associated with underlying joint inflammation or swelling.

Diagnosis

Diagnosis is primarily clinical, based on the presence of firm, subcutaneous nodules in the knee region and correlation with a history of rheumatoid arthritis. Imaging (e.g., ultrasound) may be used to assess nodule characteristics, but biopsy is rarely needed unless malignancy is suspected. Laboratory tests for RA (e.g., rheumatoid factor, anti-CCP) may support the diagnosis but are not definitive for nodules alone.

Treatment Options

Treatment focuses on managing underlying rheumatoid arthritis, as nodules often improve with disease control. Local measures (e.g., padding, avoiding pressure) may reduce discomfort. In severe cases, corticosteroid injections or surgical excision may be considered, though recurrence is possible. Biologic or targeted therapies for RA may also help reduce nodule formation.

Prognosis and Follow-Up

Prognosis depends on the severity of underlying RA. Nodules may persist or fluctuate with disease activity. Regular follow-up with a rheumatologist is recommended to monitor RA progression and adjust treatment. Nodules rarely cause functional impairment but may indicate more aggressive disease.

Complications

• Ulceration or infection of nodules, especially with trauma.
• Nerve compression if nodules grow near sensitive structures.
• Psychosocial impact due to visible lesions.

Lifestyle & Prevention

• Optimize RA management to reduce inflammation and nodule formation.
• Avoid trauma or pressure to the knee area.
• Smoking cessation, as it may exacerbate RA and nodule development.
• Regular exercise to maintain joint mobility, as advised by a healthcare provider.

When to Seek Professional Help

Seek care if nodules become painful, ulcerated, or increase in size, or if there are signs of infection (e.g., redness, drainage). Prompt evaluation is also recommended if new systemic RA symptoms (e.g., joint swelling, fatigue) develop.

Tips for Medical Coders

Use M06.369 for rheumatoid nodules localized to the unspecified knee. Document the knee as the site and confirm the association with rheumatoid arthritis. Ensure clinical correlation with RA diagnosis and specify if the knee is the only affected site to support code assignment.